Response to bortezomib of a patient with scleromyxedema refractory to other therapies

Leuk Res. 2011 Nov;35(11):e209-11. doi: 10.1016/j.leukres.2011.07.021. Epub 2011 Aug 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Pyrazines / therapeutic use*
  • Salvage Therapy*
  • Scleromyxedema / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Immunosuppressive Agents
  • Pyrazines
  • Bortezomib